Evidence map›Paper›PMID 41298984›Full record

ReviewPharmaceutical research2026

Machine Learning Prediction of Protein Adsorption on Drug-delivering Nanoparticles: A Literature Survey and Need for Future Development.

Koushiki Basu, Venkata S Chelagamsetty, Veronica A Ruiz-Avila, Tonglei Li

Abstract readReview
In one paragraph

Review in Pharmaceutical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Koushiki BasuDepartment of Industrial and Molecular Pharmaceutics, Purdue University, 575 Stadium Mall Dr., West Lafayette, IN, 47907, USA.
Venkata S ChelagamsettyDepartment of Industrial and Molecular Pharmaceutics, Purdue University, 575 Stadium Mall Dr., West Lafayette, IN, 47907, USA.
Veronica A Ruiz-AvilaDepartment of Industrial and Molecular Pharmaceutics, Purdue University, 575 Stadium Mall Dr., West Lafayette, IN, 47907, USA.
Tonglei LiDepartment of Industrial and Molecular Pharmaceutics, Purdue University, 575 Stadium Mall Dr., West Lafayette, IN, 47907, USA. tonglei@purdue.edu.ORCID http://orcid.org/0000-0003-2491-0263

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs), due to their small size and large surface area, have advanced their use as drug carriers for delivering various therapeutic molecules. When entering biological environments, nanoparticles typically adsorb proteins, forming a surface layer known as a protein corona that significantly affects the biological and therapeutic functions of a delivery system. Understanding and predicting protein adsorption is essential for optimizing nanoparticle design in drug delivery, diagnostics, and therapy. Machine learning and deep learning (ML/DL) offer promising methods for designing nanoparticles with specific properties, particularly given recent advancements in computation and nanoparticle analysis. This review explores ML/DL studies of nanoparticle-protein interactions and emphasizes the popularity of Random Forest (RF) and Deep Learning (DL) models in predicting protein corona compositions. RF models are highly valued for managing high-dimensional data and offering interpretability, which helps identify key NP features influencing protein adsorption. Conversely, DL excels at modeling non-linear relationships and detecting subtle interaction patterns. While most current research focuses on protein coronas, future models may also include other biocorona components. This is particularly relevant for soft materials, such as lipid nanoparticles (LNPs), which are now approved for delivering mRNA and peptide-based vaccines. Our findings underscore the need for advanced modeling techniques and high-quality, diverse experimental data to drive innovations in nanomedicine. Combining RF and DL approaches leverages their complementary strengths to overcome the challenge of limited experimental data and further improve NP designs for biomedical use.

Indexed as

Drug CarriersMachine LearningNanoparticlesProtein CoronaProteinsAdsorptionDeep LearningDrug Delivery SystemsHumansDrug CarriersProtein CoronaProteinsdeep learningdrug deliverymachine learningnanoparticlesprotein adsorptionprotein coronarandom forest

Identifiers

PMID41298984
PMCPMC12913329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.